Genesystem Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-8,915	-7,915	-8,996
Depreciation & Amortization	1,242	545.39	386.3
Loss (Gain) From Sale of Assets	0.18	-	3.14
Loss (Gain) From Sale of Investments	-194.97	-595.61	380.34
Loss (Gain) on Equity Investments	-	-545.52	444.93
Stock-Based Compensation	64.12	106.87	80.15
Provision & Write-off of Bad Debts	15.53	-45.25	303.51
Other Operating Activities	804.8	1,088	2,252
Change in Accounts Receivable	100.38	405.73	1,163
Change in Inventory	240.19	-417.85	-1,772
Change in Accounts Payable	-5.13	-28.99	-259.43
Change in Unearned Revenue	-	-35.02	35.02
Change in Other Net Operating Assets	-689	-373.46	-438.07
Operating Cash Flow	-7,337	-7,812	-6,417
Capital Expenditures	-258.73	-362.85	-238.43
Sale of Property, Plant & Equipment	0.55	-	-
Cash Acquisitions	-	56.11	-
Sale (Purchase) of Intangibles	-102.37	-55.96	-86.86
Investment in Securities	5,839	1,274	-2,260
Other Investing Activities	94.06	3.25	20.68
Investing Cash Flow	5,572	-85.42	-2,565
Long-Term Debt Repaid	-405.76	-88.07	-71.34
Net Debt Issued (Repaid)	-405.76	-88.07	-71.34
Issuance of Common Stock	211.57	242.47	224.33
Repurchase of Common Stock	-1,518	-	-
Other Financing Activities	-4.31	24.07	28.32
Financing Cash Flow	-1,716	178.48	181.32
Foreign Exchange Rate Adjustments	14.15	-28.68	6.32
Miscellaneous Cash Flow Adjustments	0	-	0
Net Cash Flow	-3,467	-7,747	-8,794
Free Cash Flow	-7,595	-8,174	-6,655
Free Cash Flow Margin	-628.89%	-911.27%	-182.18%
Free Cash Flow Per Share	-1109.26	-1176.26	-963.95
Cash Interest Paid	137.96	133.93	95.06
Cash Income Tax Paid	-24.3	47.01	64.87
Levered Free Cash Flow	-1,423	-8,402	-
Unlevered Free Cash Flow	-1,338	-8,319	-
Change in Net Working Capital	-4,039	2,625	-

Updated Nov 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.